James E. Ruffer
Expertise in
16
conditions

Dr. James E. Ruffer

Radiation Oncology
Radiation Oncology Consultants
1 Salt Creek Ln, 
Hinsdale, IL 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
16
conditions
Radiation Oncology Consultants
1 Salt Creek Ln, 
Hinsdale, IL 

Overview

James Ruffer is a Radiation Oncologist practicing medicine in Hinsdale, Illinois.

Dr. Ruffer is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Neuroendocrine Carcinoma of the Cervix, Cervical Cancer, Intraductal Papilloma, and Familial Prostate Cancer.

Dr. Ruffer is board certified in American Board Of Radiology, Radiation Oncology. He is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 3 clinical trials. Dr. Ruffer is currently accepting new patients.

Specialties

Radiation Oncology

Licenses

Radiology in IL

Board Certifications

American Board Of Radiology, Radiation Oncology

Hospital Affiliations

Advocate Lutheran General Hospital
Advocate Condell Medical Center
Northshore University Healthsystem - Evanston Hospital
Advocate Illinois Masonic Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

Radiation Oncology Consultants
1 Salt Creek Ln, Hinsdale, IL 60521
Other Locations
Radiation Oncology Consultants, Ltd
801 S Milwaukee Ave, Libertyville, IL 60048

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Prospective Registry Study to Evaluate the Effect of the DCISionRT Test on Treatment Decisions in Patients With DCIS Following Breast Conserving Therapy
A Prospective Registry Study to Evaluate the Effect of the DCISionRT Test on Treatment Decisions in Patients With DCIS Following Breast Conserving Therapy
Enrollment Status: Recruiting
Publish Date: April 17, 2026
Intervention Type: Other, Device
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Radiation, Drug
Study Drug: Temozolomide
Study Phase: Phase 2
A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation
A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation
Enrollment Status: Active_not_recruiting
Publish Date: July 31, 2026
Intervention Type: Other, Drug
Study Drugs: Temozolomide, Veliparib
Study Phase: Phase 2/Phase 3
View 2 Less Clinical Trial

2 Total Publications

A multi-institutional analysis of intraoperative radiotherapy for early breast cancer: Does age matter?
A multi-institutional analysis of intraoperative radiotherapy for early breast cancer: Does age matter?
Journal: American journal of surgery
Published: February 10, 2017
Similar Doctors
Expertise in
35
conditions
Dr. Vinai Gondi
Radiation Oncology
Expertise in
35
conditions
Dr. Vinai Gondi
Radiation Oncology
Referral may be required
Before you request
4405 Weaver Pkwy, 
Waterman, IL 
 (13.4 miles away)
815-334-5566
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Vinai Gondi is a Radiation Oncologist practicing medicine in Waterman, Illinois. Dr. Gondi is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Brain Tumor, Astrocytoma, Glioblastoma, Glioma, and Gamma Knife Radiosurgery. Dr. Gondi is board certified in American Board Of Radiology - Radiation Oncology (Certified). Dr. Gondi is currently accepting new patients.

Expertise in
23
conditions
Dr. Matthew M. Harkenrider
Radiation Oncology
Expertise in
23
conditions
Dr. Matthew M. Harkenrider
Radiation Oncology
Referral may be required

Dept. Of Veterans Affairs

5000 S 5th Ave, 
Hines, IL 
 (5.0 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Matthew Harkenrider is a Radiation Oncologist practicing medicine in Hines, Illinois. Dr. Harkenrider is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Lung Cancer, Small Cell Lung Cancer (SCLC), Cervical Cancer, and Prostatectomy. Dr. Harkenrider is currently accepting new patients.

Expertise in
11
conditions
Dr. Stanley L. Liauw
Radiation Oncology
Expertise in
11
conditions
Dr. Stanley L. Liauw
Radiation Oncology
Referral may be required

UChicago Medicine Duchossois Center For Advanced Medicine - Hyde Park

5758 S. Maryland Ave., 
Chicago, IL 
 (16.3 miles away)
888-824-0200
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Stanley Liauw is a Radiation Oncologist practicing medicine in Chicago, Illinois. Dr. Liauw is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Squamous Cell Carcinoma of the Anal Canal (SCAC), Anal Cancer, Prostatectomy, and Nephrectomy. Dr. Liauw is board certified in Practicing Since2006 and Radiation Oncology. Dr. Liauw is currently accepting new patients.

Frequently Asked Questions about Dr. James E. Ruffer

How do I make an appointment with Dr. James E. Ruffer?

You can book an appointment with Dr. James E. Ruffer by calling their office at 847-990-5910. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. James E. Ruffer a top-rated expert for Neuroendocrine Carcinoma of the Cervix?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. James E. Ruffer is classified as an Distinguished expert for Neuroendocrine Carcinoma of the Cervix, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. James E. Ruffer specialize in?

While Dr. James E. Ruffer is a Radiation Oncology, they have specific expertise in Neuroendocrine Carcinoma of the Cervix, Cervical Cancer, and Intraductal Papilloma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. James E. Ruffer participate in research or clinical trials?

Yes. Dr. James E. Ruffer has published 2 articles and abstracts on conditions like Neuroendocrine Carcinoma of the Cervix. You can view a list of Dr. James E. Ruffer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. James E. Ruffer accept my insurance?

Dr. James E. Ruffer accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 847-990-5910 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ruffer's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 69 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile